| Bionomics Limited : BNC105 RENAL CANCER TRIAL DATA PRESENTED AT ASCO-GU - 4-traders (press release) |
|
|
4-traders (press release) Bionomics Limited (ASX: BNO) (ADR: BMICY) announced that BNC105 clinical trial data in patients with progressive metastatic renal cancer will be presented at the American Society for Clinical Oncology 2012 Genitourinary Cancers Symposium meeting |